Abstract

The cytokine erythropoietin (EPO) is a potent inducer of erythrocyte development and one of the most prescribed biopharmaceuticals. The action of EPO on erythroid progenitor cells is well established, but its direct action on hematopoietic stem and progenitor cells (HSPCs) is still debated. Here, using cellular barcoding, we traced the differentiation of hundreds of single murine HSPCs, after ex vivo EPO-exposure and transplantation, in five different hematopoietic cell lineages, and observed the transient occurrence of high-output Myeloid-Erythroid-megaKaryocyte (MEK)-biased and Myeloid-B-cell-Dendritic cell (MBDC)-biased clones. Single-cell RNA sequencing (ScRNAseq) analysis of ex vivo EPO-exposed HSPCs revealed that EPO induced the upregulation of erythroid associated genes in a subset of HSPCs, overlapping with multipotent progenitor (MPP) 1 and MPP2. Transplantation of Barcoded EPO-exposed-MPP2 confirmed their enrichment in Myeloid-Erythroid-biased clones. Collectively, our data show that EPO does act directly on MPP independent of the niche, and modulates fate by remodeling the clonal composition of the MPP pool.

Data availability

all data and scripts are available on the github of the Perie labhttps://github.com/PerieTeam/Eisele-et-al.-

The following data sets were generated

Article and author information

Author details

  1. Almut S Eisele

    CNRS UMR168, Physico-chimie, Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Jason Cosgrove

    CNRS UMR168, Physico-chimie, Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Aurelie Magniez

    CNRS UMR168, Physico-chimie, Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Emilie Tubeuf

    CNRS UMR168, Physico-chimie, Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Sabrina Tenreira Bento

    CNRS UMR168, Physico-chimie, Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Cecile Conrad

    CNRS UMR168, Physico-chimie, Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Fanny Cayrac

    CNRS UMR168, Physico-chimie, Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Tamar Tak

    CNRS UMR168, Physico-chimie, Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Anne-Marie Lyne

    CNRS UMR168, Physico-chimie, Institut Curie, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  10. Jos Urbanus

    Immunology, The Netherlands Cancer Institute, Amsterdam, Netherlands
    Competing interests
    The authors declare that no competing interests exist.
  11. Leïla Perié

    CNRS UMR168, Physico-chimie, Institut Curie, Paris, France
    For correspondence
    leila.perie@curie.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0798-4498

Funding

Atip Avenir CNRS

  • Leïla Perié

Labex Celtisphybio (ANR-11-LABX-0038)

  • Leïla Perié

Idex Paris-Science-Lettres (ANR-10-IDEX-0001-02 PSL)

  • Leïla Perié

H2020 European Research Council (758170-Microbar)

  • Leïla Perié

H2020 Marie Skłodowska-Curie Actions (666003)

  • Almut S Eisele

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All procedures were approved by the responsible national ethics committee (APAFIS#10955-201708171446318 v1).

Copyright

© 2022, Eisele et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,571
    views
  • 246
    downloads
  • 16
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Almut S Eisele
  2. Jason Cosgrove
  3. Aurelie Magniez
  4. Emilie Tubeuf
  5. Sabrina Tenreira Bento
  6. Cecile Conrad
  7. Fanny Cayrac
  8. Tamar Tak
  9. Anne-Marie Lyne
  10. Jos Urbanus
  11. Leïla Perié
(2022)
Erythropoietin directly remodels the clonal composition of murine hematopoietic multipotent progenitor cells
eLife 11:e66922.
https://doi.org/10.7554/eLife.66922

Share this article

https://doi.org/10.7554/eLife.66922

Further reading

    1. Immunology and Inflammation
    Hella Luksch, Felix Schulze ... Angela Rösen-Wolff
    Research Article

    Constitutive activation of STING by gain-of-function mutations triggers manifestation of the systemic autoinflammatory disease STING-associated vasculopathy with onset in infancy (SAVI). In order to investigate the role of signaling by tumor necrosis factor (TNF) in SAVI, we used genetic inactivation of TNF receptors 1 and 2 in murine SAVI, which is characterized by T cell lymphopenia, inflammatory lung disease and neurodegeneration. Genetic inactivation of TNFR1 and TNFR2, however, rescued the loss of thymocytes, reduced interstitial lung disease and neurodegeneration. Furthermore, genetic inactivation of TNFR1 and TNFR2 blunted transcription of cytokines, chemokines and adhesions proteins, which result from chronic STING activation in SAVI mice. In addition, increased transendothelial migration of neutrophils was ameliorated. Taken together, our results demonstrate a pivotal role of TNFR-signaling in the pathogenesis of SAVI in mice and suggest that available TNFR antagonists could ameliorate SAVI in patients.

    1. Immunology and Inflammation
    Jian Cui, Hua Li ... Congqing Wu
    Short Report

    Systemic blood coagulation accompanies inflammation during severe infections like sepsis and COVID. We previously established a link between coagulopathy and pyroptosis, a vital defense mechanism against infection. During pyroptosis, the formation of gasdermin-D (GSDMD) pores on the plasma membrane leads to the release of tissue factor (TF)-positive microvesicles (MVs) that are procoagulant. Mice lacking GSDMD release fewer of these procoagulant MVs. However, the specific mechanisms coupling the activation of GSDMD to MV release remain unclear. Plasma membrane rupture (PMR) in pyroptosis was recently reported to be actively mediated by the transmembrane protein Ninjurin-1 (NINJ1). Here, we show that NINJ1 promotes procoagulant MV release during pyroptosis. Haploinsufficiency or glycine inhibition of NINJ1 limited the release of procoagulant MVs and inflammatory cytokines, and partially protected against blood coagulation and lethality triggered by bacterial flagellin. Our findings suggest a crucial role for NINJ1-dependent PMR in inflammasome-induced blood coagulation and inflammation.